We have observed
6 EP applications
Fatema Elyasali Sardharwala
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after March 18, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
TETRAHYDROPYRAZOLO [1,5 -A]PYRIMIDINE AS ANTI -TUBERCULOSIS COMPOUNDS
BIPHENYL DERIVATIVE AND ITS USE FOR TREATING PULMONARY DISORDERS
3-AMINO-PYRAZOLE DERIVATIVES USEFUL AGAINST TUBERCULOSIS
BENZIMIDAZOLE DERIVATIVES AS PI3 KINASE INHIBITORS
THIOTRIAZOLE COMPOUND AND ITS USE IN PARASITIC PROTOZOAL INFECTIONS
PYRAZOLO[3,4-D]PYRIMIDIN DERIVATIVE AND ITS USE FOR THE TREATMENT OF LEISHMANIASIS